Vetophage


Vetophage is dedicated to fighting antimicrobial resistance in animal health through innovative solutions based on phage proteins, endolysins, and phage capture proteins. The company develops rapid diagnostic tools and therapeutic solutions to manage bacterial infections in animals, aiming to reduce the reliance on antibiotics and promote sustainable health practices. With a strong focus on research, collaboration, and technological development, Vetophage is actively involved in projects for early detection and treatment of bacterial diseases such as bovine mastitis and canine pyoderma.

Industries

biopharma
health-care
medical

Nr. of Employees

small (1-50)

Vetophage


Products

LabMastis S.A

A rapid, field-deployable diagnostic kit using phage-derived capture proteins for detection of Staphylococcus aureus in milk and environmental samples; designed for use by veterinarians and laboratories without specialized equipment.

Endolysin-based therapeutic candidate for canine pyoderma

A veterinary therapeutic in development that uses endolysin proteins to reduce bacterial load in skin infections and support lesion healing while preserving the native microbiome; currently in preclinical/early development.


Services

Provision of phage and phage-protein collections (licence or sale)

Making collections of phages and phage-derived proteins available to manufacturers under licensing or purchase arrangements.

On-demand phage/protein discovery and custom R&D

Search and development of phages or phage proteins tailored to partner specifications, including identification and initial characterization.

Efficacy testing of phages and endolysins

Laboratory testing services to assess antibacterial activity of phages and endolysins on requested bacterial targets.

Validation and proof-of-concept studies

Design and execution of validation studies for detection kits and therapeutic concepts including independent laboratory and field studies.

Co-development and strategic partnership engagements

Collaborative development agreements and partnerships to progress diagnostic or therapeutic candidates to market.

Commercial sales and distribution of diagnostic kits

Sale of rapid diagnostic kits for veterinary use, with order/quote workflow and supporting documentation (user guides, safety data sheets).

Expertise Areas

  • Phage and phage-protein discovery
  • Diagnostic assay development for bacterial pathogens
  • Veterinary therapeutic development (endolysin-based)
  • Biobanking of biological reagents
  • Show More (4)

Key Technologies

  • Phage isolation and genotyping
  • Endolysins (phage-derived lytic enzymes)
  • Phage-derived capture proteins
  • Recombinant protein expression
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.